| Product Code: ETC6748707 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Despite the negative growth trend in China non-injectable insulin import shipments, the top exporting countries like Puerto Rico, Metropolitan France, Germany, Spain, and Italy continue to dominate the market with high concentration levels. The industry experienced a significant decline in growth rate from 2023 to 2024, indicating potential challenges or shifts in the market dynamics. It will be crucial for stakeholders to closely monitor these trends and adapt their strategies to navigate the changing landscape of non-injectable insulin imports in China.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Non-Injectable Insulin Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Non-Injectable Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 China Non-Injectable Insulin Market - Industry Life Cycle |
3.4 China Non-Injectable Insulin Market - Porter's Five Forces |
3.5 China Non-Injectable Insulin Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 China Non-Injectable Insulin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Non-Injectable Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in China |
4.2.2 Growing awareness about non-injectable insulin as a convenient treatment option |
4.2.3 Rising healthcare expenditure and government initiatives to improve diabetes care |
4.3 Market Restraints |
4.3.1 Regulatory challenges in product approval and market access |
4.3.2 High cost associated with non-injectable insulin products |
4.3.3 Limited availability and accessibility of non-injectable insulin in remote areas |
5 China Non-Injectable Insulin Market Trends |
6 China Non-Injectable Insulin Market, By Types |
6.1 China Non-Injectable Insulin Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 China Non-Injectable Insulin Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 China Non-Injectable Insulin Market Revenues & Volume, By Pills, 2021- 2031F |
6.1.4 China Non-Injectable Insulin Market Revenues & Volume, By Sprays, 2021- 2031F |
6.1.5 China Non-Injectable Insulin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Non-Injectable Insulin Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 China Non-Injectable Insulin Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.2.3 China Non-Injectable Insulin Market Revenues & Volume, By Online Stores, 2021- 2031F |
6.2.4 China Non-Injectable Insulin Market Revenues & Volume, By Drug Stores, 2021- 2031F |
7 China Non-Injectable Insulin Market Import-Export Trade Statistics |
7.1 China Non-Injectable Insulin Market Export to Major Countries |
7.2 China Non-Injectable Insulin Market Imports from Major Countries |
8 China Non-Injectable Insulin Market Key Performance Indicators |
8.1 Patient adherence rate to non-injectable insulin treatment |
8.2 Rate of adoption of non-injectable insulin by healthcare providers |
8.3 Number of research studies and clinical trials on non-injectable insulin efficacy and safety |
8.4 Patient satisfaction and feedback on non-injectable insulin products |
8.5 Market penetration rate of non-injectable insulin in different regions of China |
9 China Non-Injectable Insulin Market - Opportunity Assessment |
9.1 China Non-Injectable Insulin Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 China Non-Injectable Insulin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Non-Injectable Insulin Market - Competitive Landscape |
10.1 China Non-Injectable Insulin Market Revenue Share, By Companies, 2024 |
10.2 China Non-Injectable Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |